Publication Name	World Journal of Hepatology
Manuscript ID	17319
Country	Germany

Received	2015-03-01 17:39
Peer-Review Started	2015-03-02 14:52
To Make the First Decision	2015-04-10 16:43
Return for Revision	2015-04-15 10:39
Revised	2015-04-19 22:57
Second Decision	2015-04-30 16:09
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-05-08 16:30
Articles in Press	2015-05-08 16:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-05-29 11:33
Publish the Manuscript Online	2015-06-16 14:22

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation
Manuscript Source	Unsolicited Manuscript
All Author List	Arno Kornberg
Funding Agency and Grant Number
Corresponding Author	Arno Kornberg, MD, PhD, Department of Surgery, Klinikum rechts der Isar, Technical University, Ismaningerstr. 22, D-81675 Munich, Germany. arnokornberg@aol.com
Key Words	Intravenous immunoglobulins; Immune modulation; Hyperimmunoglobulin; Model of end-stage liver disease; Liver transplantation
Core Tip	In times of an escalating organ scarcity, decreasing posttransplant survival rates following liver transplantation have been reported. Predominantly infectious and immunologic complications were identified to account for this recent outcome deterioration. Therefore, balancing the recipients’ immune system is currently discussed as useful approach to improve prognosis. Intravenous immunoglobulins (IVIg) are thought to provide favorable immuno-regulatory capa-bilities. This paper summarizes the current available clinical data that indicate beneficial immuno-modulatory properties of IVIg in liver transplant patients.
Publish Date	2015-06-16 14:22
Citation	Kornberg A. Intravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation. World J Hepatol 2015; 7(11): 1494-1508
URL	http://www.wjgnet.com/1948-5182/full/v7/i11/1494.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i11.1494

Full Article (PDF)	WJH-7-1494.pdf
Full Article (Word)	WJH-7-1494.doc
Manuscript File	17319-Review.doc
Answering Reviewers	17319-Answering reviewers.pdf
Audio Core Tip	17319-Audio core tip.wav
Conflict-of-Interest Disclosure Form	17319-Conflict-of-interest statement.pdf
Copyright License Agreement	17319-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20150228191545.doc
Peer-review Report	17319-Peer-review(s).pdf
Scientific Misconduct Check	17319-Scientific misconduct check.pdf
Scientific Editor Work List	17319-Scientific editor work list.pdf